https://www.selleckchem.com/pr....oducts/omaveloxolone
6%), and total occlusions (5.0%). Successful delivery to the target lesion, inflation and removal of the balloon catheter was achieved in 95.5% of patients (191/20. Procedural success was achieved in 93.5% (187/20 of patients, and final TIMI 3 flow was observed in 99.0% of cases (198/20. No unanticipated device-related events occurred. In-hospital major adverse events were reported in 4.5% of patients (9/20, related to periprocedural myocardial infarction (8/200, 4.0%) and target lesion revascularization (1/200, 0.
Like
Comment
Share
